Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 2Anastomotic Leak 2Vascular Malformations 1Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Bioseal × Clear all
NCT03847857 2025-06-12

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Sun Yat-sen University

Phase 3 Active not recruiting
360 enrolled
Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT03529266 2021-08-24

PLACE020

Sun Yat-sen University

Phase 2 Completed
57 enrolled
Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT03110783 2019-11-18

Bioseal Dural Sealing Study BIOS-14-001

Guangzhou Bioseal Biotechnology Co., Ltd.

Phase 3 Completed
200 enrolled

Neoplasms, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡